Infrared Super-Continuum Laser Monitors Brain Health
By MedImaging International staff writers Posted on 10 Feb 2020 |

Image: The concussion detecting laser in human trials (Photo courtesy of Joseph Xu/ U-M)
A new study describes how a portable super-continuum device uses infrared (IR) light to monitor cytochrome C oxidase (CCO) metabolism as an indicator of brain cell distress.
Developed at the University of Michigan (U-M; Ann Arbor, USA), the new device does not monitor whether the brain is getting oxygen, but rather if the brain cells are able to use that oxygen. Research shows that CCO is excited by laser light transmitted at wavelengths of 750 to 900 nanometers (the resonant frequency). By recording levels of CCO, brain metabolism can be quantified non-invasively in-situ, for example in the emergency room (ER) or intensive care unit (ICU). The study was presented at the annual Photonics West conference, held during February 2020 in San Francisco (CA, USA).
“Concussions in athletics have been in the spotlight for the previous decade, but soldiers are also at high risk. At present, there is no one test that can diagnose a concussion. There’s no scan, no blood test, no computer test. We currently rely on a clinical exam and interpretation by the medical provider, so the diagnosis is subjective,” said Professor Steven Broglio, MD, director of the Michigan Concussion Center. “We believe this technology is the first step in changing that by measuring brain metabolism, potentially resulting in faster and more certain diagnoses.”
“This device could guide the treatment of more serious brain injuries and other conditions that put the brain at risk. In its broadest application, it could help patients whose blood pressure falls so much that there isn’t enough blood flow to keep cells functioning normally,” said trauma and emergency surgeon Rachel Russo, MD. “This would be the first device that could measure how well their brain cells are doing right in the hospital room.”
CCO is the membrane-bound enzyme that is found in essentially all organisms that utilize oxygen. It serves as the terminal constituent of the electron transport chain in the inner mitochondrial membrane, where it reduces molecular oxygen to form water, allowing adenosine triphosphate (ATP) production. The activity of CCO can be used to determine the number of active mitochondria or increase in electron transport activity in the mitochondria (energy expense or respiration rate).
Related Links:
University of Michigan
Developed at the University of Michigan (U-M; Ann Arbor, USA), the new device does not monitor whether the brain is getting oxygen, but rather if the brain cells are able to use that oxygen. Research shows that CCO is excited by laser light transmitted at wavelengths of 750 to 900 nanometers (the resonant frequency). By recording levels of CCO, brain metabolism can be quantified non-invasively in-situ, for example in the emergency room (ER) or intensive care unit (ICU). The study was presented at the annual Photonics West conference, held during February 2020 in San Francisco (CA, USA).
“Concussions in athletics have been in the spotlight for the previous decade, but soldiers are also at high risk. At present, there is no one test that can diagnose a concussion. There’s no scan, no blood test, no computer test. We currently rely on a clinical exam and interpretation by the medical provider, so the diagnosis is subjective,” said Professor Steven Broglio, MD, director of the Michigan Concussion Center. “We believe this technology is the first step in changing that by measuring brain metabolism, potentially resulting in faster and more certain diagnoses.”
“This device could guide the treatment of more serious brain injuries and other conditions that put the brain at risk. In its broadest application, it could help patients whose blood pressure falls so much that there isn’t enough blood flow to keep cells functioning normally,” said trauma and emergency surgeon Rachel Russo, MD. “This would be the first device that could measure how well their brain cells are doing right in the hospital room.”
CCO is the membrane-bound enzyme that is found in essentially all organisms that utilize oxygen. It serves as the terminal constituent of the electron transport chain in the inner mitochondrial membrane, where it reduces molecular oxygen to form water, allowing adenosine triphosphate (ATP) production. The activity of CCO can be used to determine the number of active mitochondria or increase in electron transport activity in the mitochondria (energy expense or respiration rate).
Related Links:
University of Michigan
Latest General/Advanced Imaging News
- CT Colonography Beats Stool DNA Testing for Colon Cancer Screening
- First-Of-Its-Kind Wearable Device Offers Revolutionary Alternative to CT Scans
- AI-Based CT Scan Analysis Predicts Early-Stage Kidney Damage Due to Cancer Treatments
- CT-Based Deep Learning-Driven Tool to Enhance Liver Cancer Diagnosis
- AI-Powered Imaging System Improves Lung Cancer Diagnosis
- AI Model Significantly Enhances Low-Dose CT Capabilities
- Ultra-Low Dose CT Aids Pneumonia Diagnosis in Immunocompromised Patients
- AI Reduces CT Lung Cancer Screening Workload by Almost 80%
- Cutting-Edge Technology Combines Light and Sound for Real-Time Stroke Monitoring
- AI System Detects Subtle Changes in Series of Medical Images Over Time
- New CT Scan Technique to Improve Prognosis and Treatments for Head and Neck Cancers
- World’s First Mobile Whole-Body CT Scanner to Provide Diagnostics at POC
- Comprehensive CT Scans Could Identify Atherosclerosis Among Lung Cancer Patients
- AI Improves Detection of Colorectal Cancer on Routine Abdominopelvic CT Scans
- Super-Resolution Technology Enhances Clinical Bone Imaging to Predict Osteoporotic Fracture Risk
- AI-Powered Abdomen Map Enables Early Cancer Detection
Channels
Radiography
view channel
AI Helps Radiologists Spot More Lesions in Mammograms
Breast cancer is a critical health issue, and accurate detection through mammography is essential for effective treatment. However, interpreting mammograms can be challenging for radiologists, particularly... Read more
AI Detects Fatty Liver Disease from Chest X-Rays
Fatty liver disease, which results from excess fat accumulation in the liver, is believed to impact approximately one in four individuals globally. If not addressed in time, it can progress to severe conditions... Read moreMRI
view channel
AI Model Outperforms Doctors at Identifying Patients Most At-Risk of Cardiac Arrest
Hypertrophic cardiomyopathy is one of the most common inherited heart conditions and a leading cause of sudden cardiac death in young individuals and athletes. While many patients live normal lives, some... Read more
New MRI Technique Reveals Hidden Heart Issues
Traditional exercise stress tests conducted within an MRI machine require patients to lie flat, a position that artificially improves heart function by increasing stroke volume due to gravity-driven blood... Read moreUltrasound
view channel
Pain-Free Breast Imaging System Performs One Minute Cancer Scan
Breast cancer is one of the leading causes of death for women worldwide, and early detection is key to improving outcomes. Traditional methods like mammograms and ultrasound have their limitations, particularly... Read more
Wireless Chronic Pain Management Device to Reduce Need for Painkillers and Surgery
Chronic pain affects millions of people globally, often leading to long-term disability and dependence on opioid medications, which carry significant risks of side effects and addiction.... Read moreNuclear Medicine
view channel
Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections
Mycobacteroides abscessus is a rapidly growing mycobacteria that primarily affects immunocompromised patients and those with underlying lung diseases, such as cystic fibrosis or chronic obstructive pulmonary... Read more
New Imaging Approach Could Reduce Need for Biopsies to Monitor Prostate Cancer
Prostate cancer is the second leading cause of cancer-related death among men in the United States. However, the majority of older men diagnosed with prostate cancer have slow-growing, low-risk forms of... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more